
11 - 50 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $43M Series B on 2021-11
Healthcare • Biotechnology • Pharmaceuticals
Prilenia is dedicated to developing new treatments for patients and families facing neurodegenerative diseases and neurodevelopmental disorders, such as Huntington’s disease and amyotrophic lateral sclerosis (ALS). They focus on harnessing the brain's neuroprotective capabilities, particularly through the activation of the sigma-1 receptor (S1R), to restore impaired pathways in the brain. Prilenia is advancing scientific research and exploring potential treatments to provide hope and improve the lives of patients and their families.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 August 18
Safety-PV Operations Lead managing global pharmacovigilance operations for Prilenia’s neurodegenerative therapies. Overseeing safety vendors, regulatory documents, signal management, and risk mitigation for late-stage development and commercialization.
🇺🇸 United States – Remote
💰 $43M Series B on 2021-11
⏰ Full Time
🟠 Senior
⚙️ Operations
👻 Ghost score 13%
🕒 June 25
Medical Science Liaison involved in advancing therapies for neurodegenerative diseases. Engaging with KOLs and supporting clinical trials in the U.S. and Canada.
🕒 June 8
🇺🇸 United States – Remote
💰 $43M Series B on 2021-11
⏰ Full Time
🟠 Senior
🔧 QA Engineer (Quality Assurance)
👻 Ghost score 37%
🕒 March 13
Regional Clinical Trial Manager managing clinical trial operations in neurodegeneration for biopharmaceutical company. Requires strong experience in clinical research and project management.
🍂 Massachusetts – Remote
💰 $43M Series B on 2021-11
⏰ Full Time
🟠 Senior
🔴 Lead
🧪 Clinical Research
👻 Ghost score 54%
🕒 November 17, 2025
Vice President of Clinical Operations leading global pivotal trials for neurodegenerative diseases. Driving strategy and operational excellence in a flexible, remote-focused biotech company.
🍂 Massachusetts – Remote
💰 $43M Series B on 2021-11
⏰ Full Time
🔴 Lead
🏥 Clinical Operations
👻 Ghost score 54%